Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited scores highest on Earnings (71) and lowest on Price (44). Its PosiPenta is 62.43 out of 100, better than most similar companies.
On the Penta Grid this week, Glenmark Pharmaceuticals Limited is Grid #19 of 164 in the Healthcare sector in India, and Grid #252 of 2,328 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals Limited | 62.43 | 44 | 71 | 67 | 70 | 60 |
| Alkem Laboratories Limited | 55.39 | 63 | 55 | 34 | 59 | 66 |
| Aster DM Quality Care Limited | 38.96 | 8 | 62 | 34 | 34 | 56 |
| Fortis Healthcare Limited | 36.13 | 34 | 60 | 10 | 35 | 41 |
| Biocon Limited | 41.66 | 50 | 57 | 27 | 18 | 57 |
| Abbott India Limited | 62.61 | 36 | 54 | 43 | 86 | 94 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 34.96 |
| P/B ratio | 5.98 |
EEarnings
| Trailing EPS | ₹63.69 |
| Forward EPS | ₹97.09 |
NNitro
| Price | 2226.70 |
| 52-week high | 2537.60 |
| 52-week low | 1792.60 |
| Fall from 52-week high | 12.3% |
TTorque
| Return on equity (ROE) (calculated) | 17.10% |
| Debt-to-equity | 0.06 |
AAnchor
| Beta (price swings) | 0.25 |
| Market cap | ₹62,842 Cr |
| Promoter holding | 46.65% |
| Dividend yield | 0.11% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Glenmark Pharmaceuticals Limited's PosiPenta score?
Glenmark Pharmaceuticals Limited's PosiPenta is 62.43 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Glenmark Pharmaceuticals Limited stand on the Penta Grid?
On the Penta Grid this week, Glenmark Pharmaceuticals Limited is Grid #19 of 164 in the Healthcare sector in India, and Grid #252 of 2,328 in India.
Which PosiPenta pillar is strongest for Glenmark Pharmaceuticals Limited?
Earnings (growth), with a score of 71 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Glenmark Pharmaceuticals Limited?
Price (valuation), with a score of 44 out of 100: around the middle of similar companies.
Has Glenmark Pharmaceuticals Limited's PosiPenta changed since last week?
Yes, it fell 2.69 points, from 65.12 to 62.43.
PositoAI is for research and education only and is not investment advice.